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Abstract
Background: Homeobox (HOX) genes encode transcription factors, which regulate cell proliferation, differentiation, 
adhesion, and migration. The deregulation of HOX genes is frequently associated with human reproductive system 
disorders. However, knowledge regarding the role of HOX genes in human granulosa cells is limited.
Methods: To determine the role of HOXA7 in the regulation and associated mechanisms of cell proliferation in human 
granulosa cells, HOXA7 and epidermal growth factor receptor (EGFR) expressions were examined in primary granulosa 
cells (hGCs), an immortalized human granulosa cell line, SVOG, and a granulosa tumor cell line, KGN, by real-time PCR 
and Western blotting. To manipulate the expression of HOXA7, the HOXA7 specific siRNA was used to knockdown 
HOXA7 in KGN. Conversely, HOXA7 was overexpressed in SVOG by transfection with the pcDNA3.1-HOAX7 vector. Cell 
proliferation was measured by the MTT assay.
Results: Our results show that HOXA7 and EGFR were overexpressed in KGN cells compared to hGCs and SVOG cells. 
Knockdown of HOXA7 in KGN cells significantly decreased cell proliferation and EGFR expression. Overexpression of 
HOXA7 in SVOG cells significantly promoted cell growth and EGFR expression. Moreover, the EGF-induced KGN 
proliferation was abrogated, and the activation of downstream signaling was diminished when HOXA7 was knocked 
down. Overexpression of HOXA7 in SVOG cells had an opposite effect.
Conclusions: Our present study reveals a novel mechanistic role for HOXA7 in modulating granulosa cell proliferation 
via the regulation of EGFR. This finding contributes to the knowledge of the pro-proliferation effect of HOXA7 in 
granulosa cell growth and differentiation.
Background
Ovarian follicular maturation represents one of the most
complex and clinically important developmental pro-
cesses during the reproductive life of women. Granulosa
cells surround the developing oocyte, providing a critical
microenvironment for follicular growth. Multiple granu-
losa cell dysfunctions lead to disordered ovulatory and
ovarian function [1]. Moreover, granulosa cell tumors
(GCTs) are serious ovarian neoplasms that can occur in
women of all ages [2]. As most malignant ovarian tumors
are epithelial in origin, most studies of ovarian cancer do
not include GCTs [3]. Furthermore, while much is now
known about the biology of normal granulosa cells [4],
the molecular changes that contribute to human granu-
losa cell dysfunction remain to be elucidated.
Homeobox (HOX) genes encode evolutionarily con-
served transcription factors that are essential for embry-
onic morphogenesis and differentiation [5]. Mammalians
have at least 39 HOX genes that are arranged in four clus-
ters termed HOX A, B, C, and D [6]. HOX genes exert
pleiotropic roles in many cell types and can regulate cell
proliferation, differentiation, adhesion, and migration [7].
HOX genes play important roles in organogenesis and in
the development of the human reproductive system dur-
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adults [8]. Recent studies suggest that HOX genes may
play important roles in ovarian cancer differentiation [9-
11]. However, the role of HOX genes in developing gran-
ulosa cells is not well known.
We previously demonstrated that three HOXA genes,
HOXA4, HOXA7 and HOXA10, were overexpressed in
serous ovarian adenocarcinomas when compared to
benign serous tumors or tumors with low malignant
potential. Among these genes, HOXA7 was one of the
HOX genes most consistently overexpressed in ovarian
cancers [12]. Additionally, the expression of HOXA7 was
detected in ovarian tumors exhibiting mullerian-like fea-
tures and correlated with the generation of anti-HOXA7
antibodies in patients [10]. Our studies about the role of
HOXA7 in human ovarian folliculogenesis showed that
HOXA7 expression was predominantly negative in pri-
mordial follicles and positive in primary and mature folli-
cles. Moreover, the subcellular localization of HOXA7
changed from nuclear to predominantly cytoplasmic dur-
ing follicular maturation [13]. This differential localiza-
tion indicated that HOXA7 underwent cell type- and
stage-specific changes during ovarian folliculogenesis,
which likely resulted in the regulation of granulosa cell
proliferation. Moreover, the expression of HOX cofactors
were also temporally and spatially specific in human
granulosa cells, which indicated the specific role of
HOXA7 in regulating granulose cell function [14]. How-
ever, little is known regarding the specific pathways regu-
lated by HOXA7 that promote the growth and survival of
granulosa cells.
Epidermal growth factor receptor (EGFR) belongs to
the receptor tyrosine kinase (RTK) family [15]. EGF sig-
naling plays an important role in cell growth and differen-
tiation [16]. A possible function for EGF and EGFR
signaling at select stages of follicle maturation has been
previously proposed and is supported by many observa-
tions of the effects of EGF on steroidogenesis, oocyte
maturation, and cumulus expansion [17,18]. The binding
of EGF to EGFR leads to receptor dimerization, auto-
phosphorylation and the activation of several down-
stream signaling pathways, such as the MAPK pathway
and the PI3K/Akt pathway, which play roles in cell prolif-
eration, motility, and survival [19]; these pathways have
also been shown to contribute to the abnormal growth of
several types of human cancers [20]. Recent reports have
demonstrated that HOX genes play a role in the regula-
tion of several RTK family members, including EGFR
[21], IGF1-receptor [22], and Eph-receptor [23,24], dur-
ing development. Moreover, EGFR activation has been
reported to stimulate HOXA7 expression [25].
In this study, we used siRNA and overexpression
approaches to define the role of HOXA7 in the regulation
of granulosa cell proliferation. Primary granulosa cells
(hGCs), an immortalized human granulosa cell line,
SVOG, and a granulosa tumor cell line, KGN, were used
as cell models. The KGN cell line (stocked in the RIKEN
CELL Bank) was derived from a human ovarian granu-
losa cell tumor, which expresses the functional FSH
receptor and maintains the functions of steroidogenesis
and Fas-mediated apoptosis [26]. The SVOG cell line was
produced by transfecting granulosa cells with SV40 Tag
as described previously [27]. We show that the down-reg-
ulation of HOXA7 results in decreased EGFR expression
and cell proliferation. Conversely, EGFR expression and
cell proliferation were increased by the overexpression of
HOXA7. Our findings suggest that HOXA7 is crucial for
granulosa cell proliferation and may exert its function by
regulating the expression of EGFR. These results are the
first to functionally demonstrate a link between HOXA7
expression, the regulation of proliferation and EGFR
expression in human granulosa cells.
Methods
Cells and cell culture
Primary human granulosa cells (hGCs) were obtained
with the approval of the Research Ethics Board of the
University of British Columbia. hGC isolation from follic-
ular aspirates collected during oocyte retrieval from
women undergoing in vitro fertilization was performed as
previously described [28]. In each well of six-well culture
plates, 3 × 105 viable cells were seeded and cultured in a
humidified atmosphere of 5% CO2-95% air at 37°C in 1:1
Dulbecco modified Eagle medium and Ham's F-12
medium (DMEM/F12; Sigma, St. Louis, MO, USA) sup-
plemented with 10% fetal bovine serum (FBS; Hyclone
Laboratories, Logan, UT, USA), 100 U/mL penicillin G
and 0.1 mg/mL streptomycin sulfate (Invitrogen, Burling-
ton, ON, CA). After 48 h, the hGCs were harvested from
the plate for RNA or protein extraction.
KGN cells were maintained in 1:1 DMEM/F12, supple-
mented with 10% FBS, 100 U/mL penicillin, and 0.1 mg/
mL streptomycin. The SVOG cells were maintained in
M199/MCDB105 (Invitrogen) supplemented with 10%
FBS, 100 U/mL penicillin G, and 0.1 mg/mL streptomy-
cin. In each well of six-well culture plates, 2 × 105 viable
KGN or SVOG cells were seeded, and cultures were
maintained at 37°C in a humidified atmosphere of 5%
CO2. The cells were sub-cultured when they reached
about 90% confluence using a trypsin/EDTA solution
(0.05% trypsin, 0.5 mM EDTA).
Antibodies and reagents
The monoclonal HOXA7 antibody, polyclonal EGFR
antibody and polyclonal β-actin antibody were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
The monoclonal phospho-ERK1/2 (Thr202/Tyr204) anti-
body, polyclonal total ERK1/2 antibody, polyclonal phos-
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obtained from Cell Signaling Technology (Danvers, MA,
USA). Horseradish peroxidase-conjugated goat anti-
mouse IgG and goat anti-rabbit IgG were obtained from
Bio-Rad Laboratories (Hercules, CA, USA). Horseradish
peroxidase-conjugated donkey anti-goat IgG was
obtained from Santa Cruz. Human epidermal growth fac-
tor (EGF) and the EGFR inhibitor, AG1478, were
obtained from Sigma.
Small interfering RNA (siRNA) transfection
KGN cells were cultured in growth medium as described
above to achieve approximately 50-60% confluence at the
time of transfection. Transfections were performed using
a non-targeting negative control siRNA (Dharmacon,
Chicago, IL, USA) or siRNAs against human HOXA7
(ON-TARGET plus SMART pool, Dharmacon) at a final
concentration of 75 nM using Lipofectamine RNAiMAX
(Invitrogen). Following transfection, the cells were
directly processed for mRNA/protein extraction at differ-
ent time points (24 h, 48 h and 72 h after transfection), or
reseeded into new culture plates after 36 h of transfection
for further cell viability analysis (24 h, 48 h, 72 h and 96 h
after reseeding) or EGF treatment for various periods of
time (48 h for cell viability analysis and 10 min for signal-
ing pathway detection).
Plasmid constructs and transfection
Full-length HOXA7 (917 bp) was amplified by RT-PCR
using the Phusion RT-PCR Kit (New England BioLabs,
Ipswich, MA, USA) and the following primers (5'-3'):
TCA TTC CTC CTC GTC C and ATG AGT TCT TCG
TAT TAT GAA CG. Gel-purified PCR product was
cloned into the pcDNA3.1 (+) vector using the pCR-
Blunt II-TOPO Expression Kit (Invitrogen) and con-
firmed by DNA sequencing (Child & Family Research
Institute DNA Sequencing Core Facility, Vancouver, BC,
CA). pcDNA3.1/CAT was used as a control vector.
SVOG cells were cultured in growth medium as
described above to achieve approximately 80-90% conflu-
ence at the time of transfection. Transient transfections
were carried out using Lipofectamine 2000 Reagent
(Invitrogen) following the manufacturer's protocol. After
transfection, cells were directly processed for mRNA/
protein extraction at different time points, or reseeded
into new culture plates after 36 h of transfection for fur-
ther cell viability analysis or EGF treatment for various
periods of time, as described above.
Cell growth and proliferation
Cell growth was evaluated via the 3-(4, 5-dimethyl thi-
azol-2-yl)- 2,5-diphenyl tetrazolium bromide (MTT)
assay. Briefly, 1 × 104 cells were seeded in triplicate in 96-
well plates. In some experiments, cells with or without
HOXA7 transfection were treated with EGF, AG1478, or
EGF and AG1478. At the indicated times, a final concen-
tration of MTT at 500 μg/mL (Sigma) was added and the
cells were incubated for an additional 4 h at 37°C. Follow-
ing the incubation period, DMSO was added to dissolve
the crystals. The absorbance was measured at 492 nm
and was expressed as the relative proliferation rate.
RNA extraction and Real-time PCR
At the end of the treatment period, the medium was
removed from the culture plate and RNA was extracted
using TRIzol (Invitrogen). RNA concentration was mea-
sured based on the absorbance at 260 nm. The isolated
RNA was reverse transcribed into first-strand cDNA
using M-MLV reverse transcriptase (Promega BioSci-
ences, San Luis Obispo, CA, USA). The primers used for
SYBR Green real-time RT-PCR were designed using
Primer Express Software v2.0 (PerkinElmer Applied Bio-
systems, Foster City, CA, USA). The primers for HOXA7
are: sense, 5'-TAC CCC TGG ATG CGG TCT T-3'; and
antisense, 5'-CAG GTA GCG GTT GAA GTG GAA-3'.
The primers for EGFR are: sense, 5'-CAT GTC GAT
GGA CTT CCA GA-3'; and antisense, 5'-GGG ACA
GCT TGG ATC ACA CT-3'. The primers for GAPDH
are: sense, 5'-ATG GAA ATC CCA TCA CCA TCT T-3';
and antisense, 5'-CGC CCC ACT TGA TTT TGG-3'.
Real-time PCR was performed on the ABI PRISM® 7300
Sequence Detection System according to the manufac-
turer's protocol (Applied Biosystems). Amplification
specificity was determined using the melting curve. Anal-
ysis and quantification of the relative mRNA levels was
detected using the comparative Ct method. All real-time
experiments were run in triplicate, and a mean value was
used for the determination of mRNA levels. Negative
controls containing water were used in each experiment.
Relative quantification of the mRNA levels for HOXA7
and EGFR in granulosa cells was performed using the
comparative Ct method with GAPDH as an endogenous
control. Changes following treatments were recorded as
fold differences from the values in untreated controls at
each time point, as appropriate, with the formula 2-ΔΔCt.
Western blot analysis
After treatment, cells were washed twice with ice-cold
PBS and harvested in ice-cold lysis buffer (20 mM Tris-
HCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Tri-
ton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycero-
phosphate, 1 mM Na3VO4, 1 μg/mL leupeptin)
containing protease inhibitors (Sigma). The extract was
centrifuged at 14,000 rpm for 15 min at 4°C to remove
cellular debris. Protein concentrations were determined
by the Bradford method (Bio-Rad Laboratories). SDS-
PAGE was used to further separate 30 μg of protein sam-
ple, which was then transferred onto nitrocellulose mem-
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blocked for 1 h in Tris-buffered saline containing 0.01%
Tween 20 with 5% non-fat dried milk and were incubated
overnight at 4°C with the relevant primary antibodies.
After washing, the membranes were incubated with the
secondary antibody, a peroxidase-conjugated anti-IgG for
1 h. Immunoreactive proteins were detected using
enhanced chemiluminescence reagents (Amersham Bio-
science, Baied'Urfe, Quebec, CA). For the detection of
antibody bound to HOXA7, we used the SuperSignal
Femto West (Pierce Chemical. Rockford, IL, USA)
reagent as described by the manufacturer. β-actin was
used as the internal control.
Statistical analysis
Data are presented as the means ± SEM from at least
three independent experiments. Data were analyzed by
one-way ANOVA, followed by Tukey's multiple compari-
son tests if the overall P values were significant, using the
computer software PRISM (GraphPad Software, San
Diego, CA, USA). Data were considered significantly dif-
ferent from each other at P < 0.05.
Results
HOXA7 and EGFR are expressed in human granulosa cells
Expression of HOXA7 was detected in hGCs, SVOG and
KGN cells by both real-time PCR and Western blotting.
The expression level of HOXA7 in the granulosa tumor
cell line KGN was significantly higher than in primary
granulosa cells and the immortalized human granulosa
cell line, SVOG (Fig. 1, A and 1B). EGFR expression was
also detected in all cell lines. Consistent with HOXA7,
KGN cells expressed significantly higher levels of EGFR
compared to hGCs and SVOG cells (Fig. 1, C and 1D).
HOXA7 regulates granulosa cell proliferation
To determine the functional role of endogenous HOXA7,
we used siRNA to knockdown the expression of HOXA7
in KGN cells, which expressed high levels of HOXA7.
HOXA7 knockdown was verified at the mRNA level by
real-time PCR (Fig. 2, A) and at the protein level by West-
ern blotting (Fig. 2, B). To examine the role of HOXA7 in
granulosa cell proliferation, KGN cells transfected with
HOXA7 siRNA or control siRNA were processed for the
MTT assay. In response to HOXA7 knockdown, the pro-
liferation rate of KGN cells was significantly decreased
(Fig. 2, C).
To further determine the role of HOXA7 in human
granulose cells, overexpression of HOXA7 was per-
formed in the SVOG cell line, which expressed low levels
of HOXA7. HOXA7 overexpression in SVOG cells was
also verified at both the mRNA and protein levels by real-
time PCR and Western blotting, respectively (Fig. 2, D
and 2E). Overexpression of HOXA7 significantly
increased cell proliferation in SVOG cells (Fig. 2, F).
HOXA7 regulates EGFR expression in granulosa cells
The expression level of EGFR in granulosa cells after
HOXA7 knockdown or overexpression was detected at
both the mRNA level and protein level. Knockdown of
endogenous HOXA7 in KGN cells significantly reduced
EGFR expression, especially after 48 h of transfection
(Fig. 3, A and 3B). Conversely, HOXA7 overexpression in
SVOG cells significantly increased EGFR mRNA and pro-
tein levels, especially after 48 h of transfection (Fig. 3, C
and 3D).
EGF induces granulosa cell proliferation via EGFR-mediated 
MAPK and PI3K/Akt activation
Cell viability assays showed that EGF promoted KGN and
SVOG cell proliferation, especially at the concentration
of 100 ng/mL (Fig. 4, A and 4C). Therefore, 100 ng/mL
EGF was used in the subsequent experiments. The stimu-
latory effects of EGF could be abolished by the co-treat-
ment with 1 μM of the specific EGFR inhibitor, AG1478
(Fig. 4, A and 4C). In addition, Western blotting results
demonstrated that the treatment of both KGN and SVOG
cells with EGF induced the phosphorylation of ERK1/2
and Akt, suggesting that the MAPK and PI3K/Akt signal-
ing pathways play a role in mediating the induction of
proliferation by EGF in the granulosa cell lines (Fig. 4, B
and 4D).
EGF-induced granulosa cell proliferation and downstream 
signaling activation could be modulated by the expression 
of HOXA7
Treatment with EGF significantly induced proliferation of
KGN cells; however, this effect was abrogated when
HOXA7 was knocked down by siRNA transfection (Fig.
5, A). In addition, the EGF-induced phosphorylation of
Akt was diminished after HOXA7 knockdown. Quantita-
tive analysis showed that, while the basal phosphoryla-
tion was not changed, the EGF-induced phosphorylation
of Akt was significantly decreased (Fig. 5, B). In contrast,
EGF-induced cell proliferation was enhanced in SVOG
cells after HOXA7 overexpression, and this effect could
be completely abolished by co-treatment with AG1478
(Fig. 5, C). Accordingly, the EGF-induced phosphoryla-
tion of Akt was significantly increased after HOXA7
overexpression, and this effect could also be abolished by
treatment with AG1478. However, the knockdown or
overexpression of HOXA7 did not significantly change
the phosphorylation of ERK1/2 in either cell line (Fig. 5, B
and 5D).
Discussion
HOX genes are regulatory genes encoding nuclear pro-
teins that act as transcription factors, which regulate
aspects of morphogenesis and cell differentiation. Spa-
tiotemporal aberrations in HOX gene expression have
been found with polycystic ovarian syndrome (PCOS),
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that compromise reproduction [8,29]. Moreover, there is
accumulating evidence that HOX genes play important
roles in oncogenesis, including ovarian cancer progres-
sion [30]. However, the specific role of HOX genes in
granulosa cell function and oncogenesis has not been
extensively explored. In this study, we show for the first
time a significant role for HOXA7 in the regulation of
granulosa cell proliferation and EGFR expression. These
findings indicate a new mechanism for HOX-mediated
cell proliferation that may act through the regulation of
EGFR expression.
We initially analyzed the expression level of HOXA7 in
human granulosa cells. We first demonstrated that all
three kinds of granulosa cells express HOXA7. Unlike
most HOX genes, which are expressed solely during the
embryonic period, those specific to the female reproduc-
tive tract continue to play a role in the adult [8,31]. The
expression of HOXA7 in granulosa cells indicated that
HOXA7 exerted a potential role in cell regulation. In the
current study, KGN cells were used as a granulosa tumor
cell model and SVOG cells were used as a normal granu-
losa cell model. Although SVOG cells were derived from
granulosa-luteal cells, it is still a good model for the study
of human granulosa cells as it is difficult to get human
granulosa cells at other stages [27]. Quantitative analysis
showed the expression level of HOXA7 was significantly
higher in the granulosa tumor cell line, KGN, compared
to primary hGCs and SVOG cells. It has been reported
that many cancers, including leukemia, colon, skin, pros-
tate, breast and ovarian cancers, have shown alterations
in the expression patterns of HOX genes [30,32]. The
overexpression of HOX genes has been widely associated
with a variety of ovarian carcinomas. Therefore, our
results are consistent with previous observations that
HOX genes are highly expressed in a subset of ovarian
cancers. HOXA7, in particular, plays a role in granulosa
cell growth and differentiation.
In the present study, we performed siRNA-mediated
knockdown of HOXA7 in the high HOXA7-expressing
KGN cell line. Conversely, we overexpressed HOXA7 in
the low HOXA7-expressing SVOG cell line to determine
how HOXA7 regulates granulosa cell growth. The results
show that HOXA7 exerted a specific role in granulosa cell
Figure 1 HOXA7 and EGFR expression in human granulosa cells. Expression of HOXA7 and EGFR was detected in primary hGCs, the immortalized 
human granulosa cell line, SVOG, and the granulosa tumor cell line, KGN, cells by both real-time PCR and Western blotting. (A) Real-time PCR results 
of relative HOXA7 mRNA expression. (B) The representative autoradiographs of HOXA7 detected by Western blotting (indicated by arrow). (C) Real-
time PCR results of relative EGFR mRNA expression. (D) The representative autoradiographs of EGFR detected by Western blotting. The data derived 
from at least three separate sets of experiments were standardized to the corresponding control, and the statistical results are presented in the column 
graphs. a, P < 0.05 compared with hGC; b, P < 0.05 compared with SVOG.
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in KGN proliferation, while overexpression of HOXA7 in
SVOG cells significantly promoted cell growth. A previ-
ous study indicated that HOXA7 expression was
increased during mitosis in cultured granulosa cells.
Moreover, growth differentiation factor-9 (GDF-9),
which enhances early follicular growth and differentia-
tion, increased HOXA7 protein expression and regulated
the expression of HOXA7 cofactors in granulosa cells
[13,14]. Overexpression of HOXA7 was also detected in
ovarian carcinomas [12]. These results support the
hypothesis that HOXA7 modulates the growth and onco-
genesis of human granulosa cells.
On the other hand, EGFR was also found to be overex-
pressed in granulosa tumor cells. EGFR is a transmem-
brane receptor tyrosine kinase known to be involved in
numerous cellular processes such as growth, motility and
cellular proliferation. EGF stimulates the replication of
granulosa cells, thereby inducing follicle growth [33]. The
expression levels of EGFR have been correlated with the
pathogenesis of a broad range of human cancers [34].
EGFR overexpression has been found to be a marker of
poor prognosis [35,36]. In the current study, we examined
the effect of EGF on granulosa cell growth. As observed
by others in multiple cell types [37,38], EGFR activation
in granulosa cells promoted cell proliferation and stimu-
lated the classical ERK1/2 and PI3K/Akt pathways. Those
effects could be blocked by the specific EGFR inhibitor,
AG1478. Our study further identified EGFR as a novel
downstream target of HOXA7.
While HOXA7 regulation of EGFR expression has not
been extensively studied, several reports have previously
demonstrated a relationship between receptor tyrosine
kinases and HOX genes. Henderson et al. reported that
Figure 2 HOXA7 regulates granulosa cell proliferation. KGN cells were transiently transfected with scrambled siRNA or HOXA7 siRNA and the ef-
fect of HOXA7 knockdown was verified at the mRNA level by real-time PCR (A) and protein level by Western blotting (B). (C) After 36 h of transfection, 
KGN cells were reseeded into a 96-well plate and the cell viability was detected by MTT assay. SVOG cells were transiently transfected with control 
vector or HOXA7 plasmid and the effect of HOXA7 overexpression was verified at the mRNA level by real-time PCR (D) and protein level by Western 
blotting (E). (F) After 36 h of transfection, SVOG cells were reseeded into a 96-well plate and the cell viability was detected by MTT assay. The data 
derived from at least three separate sets of experiments were standardized to the corresponding control. a, P < 0.05 compared with control siRNA or 
control vector.
Zhang et al. Reproductive Biology and Endocrinology 2010, 8:61
http://www.rbej.com/content/8/1/61
Page 7 of 10
Figure 3 HOXA7 regulates EGFR expression in granulosa cells. KGN cells were transiently transfected with scrambled siRNA or HOXA7 siRNA. Ex-
pression of EGFR was detected at the mRNA level by real-time PCR (A) and protein level by Western blotting (B). SVOG cells were transiently transfected 
with control vector or HOXA7 plasmid and expression of EGFR at the mRNA level was detected by real-time PCR (C) and at the protein level by Western 
blotting (D). The data derived from at least three separate sets of experiments were standardized to the corresponding control, and the statistical re-
sults are presented in the column graphs. a, P < 0.05 compared with control siRNA or control vector.
Figure 4 EGF induces granulosa cell proliferation via the activation of the MAPK and PI3K/Akt pathways. KGN and SVOG cells were serum 
starved for 12 h and incubated in serum-free medium containing various concentrations of EGF and/or AG1478 for various periods of time. KGN cells 
(A) and SVOG cells (C) were left untreated (Control) or treated with increasing concentrations of EGF and/or AG1478 for 48 h. The viability was mea-
sured by the MTT assay. The data derived from at least three separate sets of experiments were standardized to the corresponding control, and the 
statistical results are presented in the column graphs. a, P < 0.05 compared with control; b, P < 0.05 compared with treatment with EGF 100 ng/mL 
alone. KGN cells (B) and SVOG cells (D) were treated with 100 ng/mL EGF for 5 min, 10 min, 30 min, 1 h, 3 h or were untreated (Control). The phospho-
rylation of ERK1/2 or Akt was determined by Western blotting with specific antibodies.
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inversely correlated with EGFR expression [21]. Bruhl et
al. reported that HOXA9 bound to the EphB4 promoter
and stimulated its expression, resulting in an increase in
endothelial cell migration [23]. Recently, Whelan et al.
indicated that HOXA9 overexpression induced the
expression of another RTK member, the IGF-1 receptor,
and subsequently promoted leukemic cell growth [22]. In
the present study, we showed that the down-regulation of
HOXA7 significantly reduced EGFR mRNA and protein
expression in KGN cells. In contrast, overexpression of
HOXA7 significantly increased EGFR mRNA and protein
expression in SVOG cells. Furthermore, our results indi-
cated that EGF-induced granulosa cell proliferation and
downstream signaling activation, especially in the PI3K/
Akt pathway, could be modulated by the expression of
HOXA7. These data suggest that HOXA7 regulates the
expression of the EGF receptor in granulosa cells and,
consequently, modulates the cell proliferative capacity.
However, the detailed molecular mechanism of HOXA7-
regulated EGFR expression remains to be further eluci-
dated.
EGFR deregulation has been shown to be associated
with aberrant oocyte maturation and cumulus expansion
[39]. EGFR has also been shown to be highly expressed in
numerous types of human cancers. Therefore, the level of
EGFR expression can act as a strong prognostic factor
[35,36]. EGF is a critical regulator of cell survival
responses and downstream signaling events leading to
cell survival, thus making it an attractive target for dis-
ease therapy [37,40]. Several monoclonal antibodies or
small molecule inhibitors directed against EGFR have
been successfully used in cancer therapy [41,42]. Our
findings herein suggest that the inhibition of EGFR,
Figure 5 EGF-induced granulosa cell proliferation and activation of downstream signaling are modulated by the expression of HOXA7. KGN 
cells were transiently transfected with scrambled siRNA or HOXA7 siRNA. SVOG cells were transiently transfected with control vector or HOXA7 plas-
mid. KGN cells (A) and SVOG cells (C) were reseeded into a 96-well plate after 36 h of transfection. Cells were serum starved for 12 h and incubated in 
serum-free medium containing 100 ng/mL EGF and/or AG1478, or were left untreated (Control) for 48 h. Cell viability was measured by the MTT assay. 
KGN cells (B) and SVOG cells (D) were serum starved for 12 h after 36 h transfection and incubated in serum free medium containing 100 ng/mL EGF 
and/or AG1478, or left untreated (Control) for 10 min. The phosphorylation of ERK1/2 or Akt was determined by Western blotting with specific anti-
bodies. The data derived from at least three separate sets of experiments were standardized to the corresponding control, and the statistical results 
are presented in the column graphs. a, P < 0.05 compared with control; b, P < 0.05 compared with control siRNA or control vector transfection and 
EGF treatment. c, P < 0.05 compared with EGF treatment alone.
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other approaches, might be a good approach for the treat-
ment of granulosa cell proliferation dysfunction, granu-
losa cell tumors or other cancers that exhibit elevated
HOX gene expression. Certainly, EGF signaling alone is
not sufficient to maintain cell survival indefinitely.
HOXA7 may also affect additional proteins. Therefore,
our observations and the interest in granulosa cell thera-
pies require further investigation at the clinical and basic
science levels.
In summary, our present data support a novel mecha-
nistic role for the HOXA7 modulation of granulosa cell
proliferation via the expression of EGFR. This finding
contributes to the pro-proliferation effect of HOXA7 in
granulosa cell growth and differentiation. This pathway
will yield new potential targets for the treatment of gran-
ulosa cell tumors and other granulosa cell proliferation
dysfunction that involve the aberrant expression of HOX
genes.
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